FDA 510(k) Cybersecurity Testing

Cybersecurity testing deliverables that support FDA premarket review include:

• Cybersecurity test plans that define test objectives, scope, and risk-based rationale.
• Summaries of vulnerability assessment and penetration testing results with traceability to identified risks and implemented risk control measures.
• Documentation formatted for FDA review, including narrative descriptions, tables, and traceability matrices.
• Support for integrating cybersecurity testing evidence into the overall FDA 510(k) submission structure.

Sponsors typically provide inputs such as:

• Device architecture descriptions and software design documentation.
• Cybersecurity risk analyses, threat models, or security risk assessments.
• Existing cybersecurity testing artifacts, including vulnerability assessments and penetration testing results, where available.
• Intended regulatory pathway and submission format (e.g., eSTAR).

Cybersecurity testing support applies to:

• Manufacturers of software-enabled or connected medical devices that include cybersecurity information as part of an FDA 510(k) submission.
• Regulatory and quality teams that prepare and maintain submission-ready documentation.
• Engineering and product teams that implement and verify cybersecurity risk control measures.
• Organizations that seek to align internal cybersecurity testing activities with FDA premarket review expectations.